Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

JAK Inhibitors in Psoriatic Disease
Matteo Megna, Luca Potestio, Angelo Ruggiero, et al.
Clinical Cosmetic and Investigational Dermatology (2023) Vol. Volume 16, pp. 3129-3145
Open Access | Times Cited: 14

Showing 14 citing articles:

Advances in psoriasis research: From pathogenesis to therapeutics
Dineshwar Sugumaran, Audrey Chee Hui Yong, Johnson Stanslas
Life Sciences (2024) Vol. 355, pp. 122991-122991
Closed Access | Times Cited: 11
Psoriasis and Molecular Target Therapies: Evidence of Efficacy in Preventing Cardiovascular Comorbidities
Luca Potestio, Nello Tommasino, Giuseppe Lauletta, et al.
Dermatology and Therapy (2024) Vol. 14, Iss. 4, pp. 841-852
Open Access | Times Cited: 5
Therapeutic Potential of Targeting the JAK/STAT Pathway in Psoriasis: Focus on TYK2 Inhibition
Martina Dragotto, Martina D’Onghia, Emanuele Trovato, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 11, pp. 3091-3091
Open Access | Times Cited: 3
Biological therapy for psoriatic arthritis: current state and future perspectives
Dominika Boboryko, Joanna Olejnik-Wojciechowska, Magdalena Baranowska, et al.
Rheumatology International (2024)
Closed Access | Times Cited: 1
The regulatory T cell-selective interleukin-2 receptor agonist rezpegaldesleukin in the treatment of inflammatory skin diseases: two randomized, double-blind, placebo-controlled phase 1b trials
Jonathan I. Silverberg, David Rosmarin, Raj Chovatiya, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Efficacy and safety of the regulatory T cell-selective interleukin-2 receptor agonist rezpegaldesleukin (REZPEG) in the treatment of inflammatory skin diseases including atopic dermatitis
Jonathan Zalevsky, Jonathan I. Silverberg, David Rosmarin, et al.
Research Square (Research Square) (2024)
Open Access
Long-Term Outcomes of Patients with Biologically Treated Psoriatic Arthritis and Atopic Dermatitis—A Single-Center Experience
Georgiana Strugariu, Cristina Pomîrleanu, Mara Russu, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 4, pp. 427-427
Open Access
Nonclinical evaluations of deucravacitinib and Janus kinase inhibitors in homeostatic and inflammatory pathways
Brandon M. Johnson, Lihong Cheng, Jennifer Koenitzer, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Cardiovascular events in patients with psoriasis and psoriatic arthritis treated with JAK/TYK inhibitors: A systematic review and meta‐analysis
Marina Burlá, Izabela Pera Calvi, Regina Chahine Chater, et al.
Journal of the European Academy of Dermatology and Venereology (2024)
Open Access
Biologics and Small Molecules for Inflammatory Nail Disorders: A Narrative Review
Carrie A. Forman, Shari R. Lipner
Indian Dermatology Online Journal (2024) Vol. 16, Iss. 1, pp. 50-58
Open Access
JAKinhibs in Psoriatic Disease: Analysis of the Efficacy/Safety Profile in Daily Clinical Practice
Francesco Pio Bizzarri, Ricardo Ruíz‐Villaverde, Pilar Morales-Garrido, et al.
(2024)
Open Access
JAKinhibs in Psoriatic Disease: Analysis of the Efficacy/Safety Profile in Daily Clinical Practice
Francesco Pio Bizzarri, Ricardo Ruíz‐Villaverde, Pilar Morales-Garrido, et al.
Diagnostics (2024) Vol. 14, Iss. 10, pp. 988-988
Open Access
Novel pharmacotherapies and breakthroughs in psoriasis treatment: 2024 and beyond
Antonio Portarapillo, Luca Potestio, Nello Tommasino, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 9, pp. 1187-1198
Closed Access
Use of tofacitinib in psoriatic arthritis (literature review)
И. А. Шафиева, С. В. Булгакова, Д. П. Курмаев, et al.
Meditsinskiy sovet = Medical Council (2024), Iss. 12, pp. 114-122
Open Access
Page 1

Scroll to top